Altimmune Inc (NASDAQ: ALT): The Best-Of-Breed For Investing?
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $10.87 million. In addition, The Vanguard Group, […]
